The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment

Behavioural Brain Research

Volumn 141, Issue 1, 2003, Pages 11-17

  Rubaj, Andrzej ^a   Zgodziński, Witold ^a   Sieklucka Dziuba, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Adenosine; Memory; MK 801; Scopolamine

Indexed keywords

1 DEOXY 1 [6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURIN 9 YL] N METHYL(DEXTRO RIBOFURANURONAMINE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A3 RECEPTOR AGONIST; DIZOCILPINE; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LEARNING DISORDER; LOCOMOTION; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRAINING;

ADENOSINE; ANIMALS; AVOIDANCE LEARNING; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; SCOPOLAMINE; THEOPHYLLINE;

EID: 0037451819     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00314-5     Document Type: Article

References (51)

1. Abbracchio M.P., Brambilla R., Ceruti S., Kim H.O., von Lubitz D.K., Jacobson K.A., Cattabeni F. G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol. Pharmacol. 48:1995;1038-1045.
2. Abel T., Nguyen P.V., Barad M., Deuel T.A., Kandel E.R., Bourtchouladze R. Genetic demons-based long-term memory. Cell. 88:1997;615-626.
3. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18:1998;5545-5554.
4. Aprikyan G.V., Gekchyan K.G. Release of neurotransmitter amino acids from rat brain synaptosomes and its regulation in aging. Gerontology. 34:1988;35-40.
5. Arai A., Kessler M., Lynch G. The effects of adenosine on the development of long-term potentiation. Neurosci. Lett. 119:1990;41-44.
6. Auerbach J.M., Segal M. A novel cholinergic induction of long-term potentiation in rat hippocampus. J. Neurophysiol. 72:1994;2034-2040.
7. Bartus J.D., Johnson H.R. Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine. Pharmacol. Biochem. Behav. 5:1976;39-46.
8. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
9. Brion J.P. The neurobiology of Alzheimer's disease. Acta Clin. Belg. 51:1996;80-90.
10. Costenla A.R., Lopes L.V., de Mendonca A., Ribeiro J.A. A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci. Lett. 302:2001;53-57.
11. Cunha R.A., Vizi E.S., Ribeiro J.A., Sebastião A.M. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J. Neurochem. 67:1996;2180-2187.
12. Dunwiddie T.V., Diao L., Kim H.O., Jiang J.L., Jacobson K.A. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J. Neurosci. 17:1997;607-614.
13. Fleming K.M., Mogul D.J. Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway. Neuropharmacology. 36:1997;353-362.
14. Fozard J.R., Pfannkuche H.J., Schuurman H.J. Mast cell degranulation following adenosine A3 receptor activation in rats. Eur. J. Pharmacol. 298:1996;293-297.
15. Giovannelli L., Giovannini M.G., Pedata F., Pepeu G. Purinergic modulation of cortical acetylcholine release is decreased in aging rats. Exp. Gerontol. 23:1988;175-181.
16. Greenamyre J.T., Penney J.B., D'Amato C.J., Young A.B. Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding. J. Neurochem. 48:1987;543-551.
17. Jacobson K.A., Nikodijevic O., Shi D., Gallo-Rodriguez C., Olah M.E., Stiles G.L., Daly J.W. A role for central A3-adenosine receptors. Mediation of behavioral depressant effects. FEBS Lett. 336:1993;57-60.
18. Jerusalinsky D., Kornisiuk E., Izquierdo I. Cholinergic neurotransmission and synaptic plasticity concerning memory processing. Neurochem. Res. 22:1997;507-515.
19. 6-benzyladenosine-5′-uronamides enhances selectivity for A3 adenosine receptors. J. Med. Chem. 37:1994;3614-3621.
20. Kim J.S., Kornhuber H.H., Schmid-Burgk W., Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20:1980;379-382.
21. Linden D.J. Long-term synaptic depression in the mammalian brain. Neuron. 12:1994;457-472.
22. Loscher W., Annies R., Honack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:1991;191-194.
23. Macek T.A., Schaffhauser H., Conn P.J. Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J. Neurosci. 18:1998;6138-6146.
24. Martin S.J., Grimwood P.D., Morris R.G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23:2000;649-711.
25. Matsuoka N., Maeda N., Yamazaki M., Ohkubo Y., Yamaguchi I. Effect of FR121196: A novel cognitive enhancer, on the memory impairments of rats in passive avoidance and radial arm maze tasks. J. Pharmacol. Exp. Ther. 263:1992;436-444.
26. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of sigma ligands in memory processes. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647:1994;44-56.
27. Mendonca A., Ribeiro J.A. 2-Chloroadenosine decreases long-term potentiation in the hippocampal CA1 area of the rat. Neurosci. Lett. 118:1990;107-111.
28. Messer W.S., Thomas G.J., Hoss W.P. Selectivity of pirenzepine in the central nervous system. Differential effects of pirenzepine and scopolamine on performance of a representational memory task. Brain Res. 407:1987;37-45.
29. Mesulam M.M. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog. Brain Res. 109:1996;285-297.
30. Miller K.J., Hoffman B.J. Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J. Biol. Chem. 269:1994;27351-27356.
31. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17:1997;2921-2927.
32. Mondadori C., Weiskrantz L. NMDA receptor blockers facilitate and impair learning via different mechanisms. Behav. Neural Biol. 60:1993;205-210.
33. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
34. Palmer A.M. Neurochemical studies of Alzheimer's disease. Neurodegeneration. 5:1996;381-391.
35. Parada-Turska J., Turski W.A. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology. 29:1990;1111-1116.
36. Parsons M.W., Gold P.E. Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose. Behav. Neural Biol. 57:1992;90-92.
37. Penney J.B., Maragos W.F., Greenamyre J.T., Debowey D.L., Hollingsworth Z., Young A.B. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias. J. Neurol. Neurosurg. Psychiatry. 53:1990;314-320.
38. Pitkanen M., Sirvio J., MacDonald E., Niemi S., Ekonsalo T., Riekkinen P.S. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks. Eur. Neuropsychopharmacol. 5:1995;457-463.
39. Ribeiro J.A. Purinergic inhibition of neurotransmitter release in the central nervous system. Pharmacol. Toxicol. 77:1995;299-305.
40. Rivkees S.A., Thevananther S., Hao H. Are A3 adenosine receptors expressed in the brain. NeuroReport. 11:2000;1025-1030.
41. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berlin). 94:1988;491-495.
42. Sitaram N., Weingartner H., Gillin J.C. Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Science. 211:1978;274-276.
43. Stone W.S., Walser B., Gold S.D., Gold P.E. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav. Neurosci. 105:1991;264-271.
44. Tanaka Y., Sakurai M., Goto M., Hayashi S. Effect of xanthine derivatives on hippocampal long-term potentiation. Brain Res. 522:1990;63-68.
45. Ukai M., Shinkai N., Ohashi K., Kameyama T. Substance P markedly ameliorates scopolamine-induced impairment of spontaneous alternation performance in the mouse. Brain Res. 673:1995;335-338.
46. Ukai M., Shinkai N., Kameyama T. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice. Nihon Shinkei Seishin Yakurigaku Zasshi. 16:1996;97-101.
47. Warburton D.M., Heise G.A. Effects of scopolamine on spatial double alternation in rats. J. Comp. Physiol. Psychol. 81:1972;523-532.
48. Watts J., Stevens R., Robinson C. Effects of scopolamine on radial maze performance in rats. Physiol. Behav. 26:1981;845-851.
49. Wedzony K., Czyrak A. The distribution of the NMDA R1 subunit in the rat hippocampus - an immunocytohistochemical study. Brain Res. 768:1997;333-337.
50. Wedzony K., Klimek V., Golebiowska K. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res. 622:1993;325-329.
51. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem. 58:1992;1573-1575.